Chronic hepatitis

There are 10 papers on chronic hepatitis in aging research: 3 trials and 5 observational studies in people, 1 in animals, 1 review. The newest story, Oct 5, 2026: “Becoming active is linked to lower mortality in chronic hepatitis B”.

Disease

10 papers study it110 more mention it1 finding

8 new papers in 30 daysSee all 120

  • Human trial3
  • Humans5
  • Animals1

Effects

1

P21 immunopositivity

upin dogs1

1 study
  1. Chronic hepatitis increases P21 immunopositivity in dogs (compared with control dogs with normal liver histology) (median 90% positive hepatocytes (range 20%-98%)).

    “Hepatocyte p21 immunopositivity in dogs with CH was high (median percentage of positive hepatocytes: 90%, range: 20%-98%)”

    Animalscompared with control dogs with normal liver histologylivern = 26

    Hepatocyte expression and prognostic importance of senescence marker p21 in liver histopathology samples from dogs with chronic hepatitis

    Journal of veterinary internal medicine

More on P21 immunopositivity

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 4Feb 2026: 4Mar 2026: 8Apr 2026: 2May 2026: 0Jun 2026: 3Jul 2026: 1Aug 2026: 5Sep 2026: 7Oct 2026: 7Nov 2026: 041 papers in 12 months
Journal of Viral Hepatitis

Becoming active is linked to lower mortality in chronic hepatitis B

Initiating moderate-to-vigorous physical activity was associated with an all-cause mortality hazard ratio of 0.89 compared with remaining inactive over a median 7.9-year…Initiating moderate-to-vigorous physical activity was associated with an all-cause mortality hazard ratio of 0.89 compared with remaining inactive over a median 7.9-year follow-up.

Cohort study of 318,131 peopleChronic hepatitis B

See all 120